Jay Matushak - Mar 6, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Chief Financial Officer
Signature
/s/ Eric Halverson for Jay Matushak, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 07:39 PM
Previous filing
Oct 6, 2023
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +6.34K +221.64% 9.2K Mar 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -6.34K -33.34% $0.00 12.7K Mar 6, 2024 Common Stock 6.34K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These restricted stock units vest in three equal annual installments beginning on March 6, 2024.